Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
- Sponsor
- British Thoracic Society
- Study ID
- NCT00030459
- Phase
- PHASE2
- Status
- Unknown
Conditions
- Malignant Mesothelioma
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- cisplatin — DRUG
- mitomycin C — DRUG
- vinblastine sulfate — DRUG
- vinorelbine tartrate — DRUG
Study Details
RATIONALE: Palliative therapy may help patients with advanced cancer live more comfortably. It is not yet known if palliative therapy is more effective with or without chemotherapy in treating patients who have malignant mesothelioma. PURPOSE: Randomized phase II trial to compare the effectiveness of palliative therapy with or without different chemotherapy regimens in treating patients who have malignant mesothelioma.
Key Dates
- Start date
- Nov 30, 2000
- Status verified
- May 2003
Study Design
- Allocation
- RANDOMIZED
- Primary purpose
- TREATMENT
Related Studies
- Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by SurgeryPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Chicago, Illinois
- Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid TumorsPHASE1 · Recruiting · InSilico Medicine Hong Kong Limited · Denver, Colorado
- Fast TILs to Treat Metastatic Cancer Patients With Pleural DiseasePHASE1 · Recruiting · David Bartlett, MD · Pittsburgh, Pennsylvania